News

Zai Lab Limited announced that the U.S. Food and Drug Administration has granted Fast Track Designation to Zocilurtatug pelitecan, also known as zoci and formerly identified as ZL-1310,…
Read More...

Isomorphic Labs announced that it has secured $2.1 billion in Series B financing to expand its artificial intelligence-powered drug discovery and development platform, marking one of…
Read More...

New Phase III clinical trial results presented at the European Congress of Endocrinology in Prague showed that Eneboparatide achieved significant improvements in calcium regulation and…
Read More...

GSK has announced an exclusive strategic collaboration with Sino Biopharmaceutical through its subsidiary Chia Tai Tianqing Pharmaceutical Group to accelerate the launch and…
Read More...

Bristol Myers Squibb announced that the European Commission has approved Sotyktu for the treatment of adults with active psoriatic arthritis (PsA) who have had an inadequate response or…
Read More...

The U.S. Food and Drug Administration has launched a new initiative aimed at accelerating the development of treatments for patients with unmet medical needs by exploring new uses for…
Read More...

Partner Therapeutics announced that the U.S. Food and Drug Administration has approved BIZENGRI for the treatment of adults with advanced, unresectable, or metastatic cholangiocarcinoma…
Read More...

Swiss healthcare giant Roche has signed a definitive merger agreement to acquire U.S.-based artificial intelligence pathology company PathAI, strengthening its position in the rapidly…
Read More...

Altasciences and Certara have announced a strategic partnership aimed at accelerating early-stage drug development by integrating advanced modeling and simulation technologies into…
Read More...

Italian drugmaker Angelini Pharma has agreed to acquire U.S.-based rare disease specialist Catalyst Pharmaceuticals in a cash transaction valued at approximately $4.1 billion, marking…
Read More...

Novartis has begun construction on a new radioligand therapy (RLT) manufacturing facility in Denton, Texas, as part of the company’s expanding multibillion-dollar investment in U.S.…
Read More...

Eli Lilly and Company has announced an additional $4.5 billion investment in its Lebanon, Indiana manufacturing operations, strengthening the pharmaceutical giant’s long-term commitment…
Read More...

Artera has received U.S. Food and Drug Administration clearance for its ArteraAI Breast test, marking a significant milestone in the use of artificial intelligence for cancer…
Read More...

Halozyme Therapeutics and Oruka Therapeutics have entered into a global exclusive collaboration and licensing agreement focused on advancing innovative drug delivery technology for…
Read More...

Waiv, formerly known as Owkin Dx, has entered into a collaboration with Daiichi Sankyo to support digital pathology biomarker discovery for an antibody-drug conjugate (ADC) development…
Read More...

MSD has announced the successful completion of its acquisition of Terns Pharmaceuticals, Inc., marking a significant move to strengthen its oncology pipeline and expand its portfolio of…
Read More...

Madrigal Pharmaceuticals, Inc. has entered into an exclusive global licensing agreement with Arrowhead Pharmaceuticals to develop and commercialize ARO-PNPLA3, a clinical-stage…
Read More...

Citius Oncology, Inc. has announced a combined financing package of up to $36.5 million aimed at accelerating the commercialization of its cancer therapy LYMPHIR®. The funding includes…
Read More...

Latus Bio, Inc. has secured $97 million in Series A financing to accelerate the development of its gene therapy pipeline, marking a significant milestone for the early-stage biotech…
Read More...

The U.S. Food and Drug Administration has approved LANGLARA™ (insulin glargine-aldy), a biosimilar to Lantus® (insulin glargine), offering a potentially more affordable treatment option…
Read More...